IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer

Biochemical and Biophysical Research Communications

Volumn 343, Issue 4, 2006, Pages 995-1001

  Cui, Xiaoyan ^a   Yang, Seok Chul ^a,b   Sharma, Sherven ^a,b   Heuze Vourc'h, Nathalie ^a   Dubinett, Steven M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

15 PGDH; COX 2; IL 4; mPGES 1; NSCLC; PGE2

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 4;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EVALUATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; INTERLEUKIN-1; INTERLEUKIN-4; INTRAMOLECULAR OXIDOREDUCTASES; LUNG NEOPLASMS; MEMBRANE PROTEINS; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 33646482914     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.073     Document Type: Article

References (32)

1. Dohadwala M., Batra R.K., Luo J., Lin Y., Krysan K., Pold M., Sharma S., and Dubinett S.M. Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J. Biol. Chem. 277 (2002) 50828-50833
2. Sheng H., Shao J., Morrow J.D., Beauchamp R.D., and DuBois R.N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58 (1998) 362-366
3. Stolina M., Sharma S., Lin Y., Dohadwala M., Gardner B., Luo J., Zhu L., Kronenberg M., Miller P.W., Portanova J., Lee J.C., and Dubinett S.M. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol. 164 (2000) 361-370
4. Pold M., Zhu L.X., Sharma S., Burdick M.D., Lin Y., Lee P.P., Pold A., Luo J., Krysan K., Dohadwala M., Mao J.T., Batra R.K., Strieter R.M., and Dubinett S.M. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer. Cancer Res. 64 (2004) 1853-1860
5. Herschman H.R. Function and regulation of prostaglandin synthase 2. Adv. Exp. Med. Biol. 469 (1999) 3-8
6. Dubinett S.M., Sharma S., Huang M., Dohadwala M., Pold M., and Mao J.T. Cyclooxygenase-2 in lung cancer. Prog. Exp. Tumor. Res. 37 (2003) 138-162
7. Dannenberg A.J., and Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 4 (2003) 431-436
8. Huang M., Wang J., Lee P., Sharma S., Mao J.T., Meissner H., Uyemura K., Modlin R., Wollman J., and Dubinett S.M. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55 (1995) 3847-3853
9. Niiro H., Otsuka T., Izuhara K., Yamaoka K., Ohshima K., Tanabe T., Hara S., Nemoto Y., Tanaka Y., Nakashima H., and Niho Y. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89 (1997) 1621-1628
10. Niiro H., Otsuka T., Ogami E., Yamaoka K., Nagano S., Akahoshi M., Nakashima H., Arinobu Y., Izuhara K., and Niho Y. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem. Biophys. Res. Commun. 250 (1998) 200-205
11. Heuze-Vourc'h N., Zhu L., Krysan K., Batra R.K., Sharma S., and Dubinett S.M. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells. Cancer Res. 63 (2003) 766-770
12. Huang M., Stolina M., Sharma S., Mao J.T., Zhu L., Miller P.W., Wollman J., Herschman H., and Dubinett S.M. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res. 58 (1998) 1208-1216
13. Inoue H., Nanayama T., Hara S., Yokoyama C., and Tanabe T. The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells. FEBS Lett. 350 (1994) 51-54
14. Taniura S., Kamitani H., Watanabe T., and Eling T.E. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J. Biol. Chem. 277 (2002) 16823-16830
15. Schneider N., Lanz S., Ramer R., Schaefer D., and Goppelt-Struebe M. Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids. J. Neurochem. 77 (2001) 416-424
16. Shao J., Sheng H., Inoue H., Morrow J.D., and DuBois R.N. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J. Biol. Chem. 275 (2000) 33951-33956
17. Chun K.S., and Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68 (2004) 1089-1100
18. Nieminen R., Leinonen S., Lahti A., Vuolteenaho K., Jalonen U., Kankaanranta H., Goldring M.B., and Moilanen E. Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes. Mediators Inflamm. 2005 (2005) 249-255
19. Fukushima H., Jimi E., Okamoto F., Motokawa W., and Okabe K. IL-1-induced receptor activator of NF-kappa B ligand in human periodontal ligament cells involves ERK-dependent PGE2 production. Bone 36 (2005) 267-275
20. Yoshino O., Osuga Y., Hirota Y., Koga K., Hirata T., Harada M., Morimoto C., Yano T., Nishii O., Tsutsumi O., and Taketani Y. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am. J. Reprod. Immunol. 52 (2004) 306-311
21. Lin C.C., Sun C.C., Luo S.F., Tsai A.C., Chien C.S., Hsiao L.D., Lee C.W., Hsieh J.T., and Yang C.M. Induction of cyclooxygenase-2 expression in human tracheal smooth muscle cells by interleukin-1beta: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kappaB. J. Biomed. Sci. 11 (2004) 377-390
22. Yang C.M., Chien C.S., Hsiao L.D., Luo S.F., and Wang C.C. Interleukin-1beta-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, NF-kappaB pathways in canine tracheal smooth muscle cells. Cell Signal. 14 (2002) 899-911
23. Fan X.M., Wong B.C., Lin M.C., Cho C.H., Wang W.P., Kung H.F., and Lam S.K. Interleukin-1beta induces cyclo-oxygenase-2 expression in gastric cancer cells by the p38 and p44/42 mitogen-activated protein kinase signaling pathways. J. Gastroenterol. Hepatol. 16 (2001) 1098-1104
24. Jakobsson P.J., Thoren S., Morgenstern R., and Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA 96 (1999) 7220-7225
25. Tanikawa N., Ohmiya Y., Ohkubo H., Hashimoto K., Kangawa K., Kojima M., Ito S., and Watanabe K. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem. Biophys. Res. Commun. 291 (2002) 884-889
26. Tanioka T., Nakatani Y., Semmyo N., Murakami M., and Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275 (2000) 32775-32782
27. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., Ikeda T., Fueki M., Ueno A., Oh S., and Kudo I. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275 (2000) 32783-32792
28. Murakami M., Nakashima K., Kamei D., Masuda S., Ishikawa Y., Ishii T., Ohmiya Y., Watanabe K., and Kudo I. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278 (2003) 37937-37947
29. Yoshimatsu K., Altorki N.K., Golijanin D., Zhang F., Jakobsson P.J., Dannenberg A.J., and Subbaramaiah K. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin. Cancer Res. 7 (2001) 2669-2674
30. +-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Carcinogenesis 26 (2005) 65-72
31. Vokes E.E., Figlin R., Hochster H., Lotze M., and Rybak M.E. A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer. Cancer J. Sci. Am. 4 (1998) 46-51
32. Gitlitz B.J., Figlin R.A., Kiertscher S.M., Moldawer N., Rosen F., and Roth M.D. Phase I trial of granulocyte macrophage-colony stimulating factor and interleukin-4 as a combined immunotherapy for patients with cancer. J. Immunother. 26 (2003) 171-178